MF
EVH icon

Magnetar Financial’s Evolent Health EVH Stock Holding History

Magnetar Financial’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,633
Closed -$238K – 824
2022
Q3 		$238K Buy
+6,633
New +$234K ﹤0.01% 899
2017
Q3 		– Sell
-100,000
Closed -$2.54M – 774
2017
Q2 		$2.54M Buy
+100,000
New +$2.41M 0.04% 203

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Magnetar Financial's EVH Position: Q4 2022 in Review

Magnetar Financial sold out of Evolent Health (EVH) in Q4 2022, closing a stake of 6,633 shares — an estimated $238K sold.

Magnetar Financial first reported a position in EVH in Q2 2017 and held it in 2 quarters. The position peaked at $2.54M in Q2 2017. 232 funds tracked by Wall St. Rank hold EVH as of Q4 2022.

  • Magnetar Financial reported no remaining Evolent Health position as of Q4 2022 after selling out during the quarter.
  • Magnetar Financial sold 6,633 Evolent Health shares in Q4 2022, an estimated $238K.
  • Magnetar Financial first reported a position in Evolent Health in Q2 2017 and held it in 2 quarters.
  • Magnetar Financial's Evolent Health position peaked at $2.54M in Q2 2017.
  • 232 funds tracked by Wall St. Rank held Evolent Health as of Q4 2022.

Based on Magnetar Financial's 13F filing for Q4 2022, filed 14 Feb 2023.